Evidence map›Paper›PMID 36325938›Full record

ArticleSoft matter2022

AGE-breaker ALT711 reverses glycation-mediated cancer cell migration.

Matthew M Rowe, Wenjun Wang, Paul V Taufalele, Cynthia A Reinhart-King

Open access · greenAbstract read
In one paragraph

Article in Soft matter, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Premetastatic niche mechanics and organotropism in breast cancer.npj biological physics and mechanics · 2025
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Matthew M RoweDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA. cynthia.reinhart-king@vanderbilt.edu.ORCID http://orcid.org/0000-0002-0762-185X
Wenjun WangDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA. cynthia.reinhart-king@vanderbilt.edu.ORCID http://orcid.org/0000-0003-0907-6282
Paul V TaufaleleDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA. cynthia.reinhart-king@vanderbilt.edu.
Cynthia A Reinhart-KingDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA. cynthia.reinhart-king@vanderbilt.edu.ORCID http://orcid.org/0000-0001-6959-3914
Vanderbilt University · US

Funding

TISSUE CoreP50CA098131 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PARK, BEN HO, PIETENPOL, JENNIFER A · 2003 to 2024
$48.7M
Mechanical Regulation of Tumor AngiogenesisR01HL127499 · NHLBI · VANDERBILT UNIVERSITY · PI REINHART-KING, CYNTHIA A. · 2015 to 2019
$2.4M
Molecular Determinants of Confined MigrationR01GM131178 · NIGMS · VANDERBILT UNIVERSITY · PI MARKOV, DMITRY · 2019 to 2022
$1.5M
Matrix stiffness mediated biglycan expression in the tumor vasculatureF31HL154727 · NHLBI · VANDERBILT UNIVERSITY · PI TAUFALELE, PAUL · 2020 to 2022
$129k
Diabetes Mellitus Promotes Breast Tumor Progression via Glycation Mediated Matrix StiffeningF99CA274695 · NCI · VANDERBILT UNIVERSITY · PI WANG, WENJUN · 2022 to 2023
$96k
NCI NIH HHS F99 CA274695NCI NIH HHS P50 CA098131NHLBI NIH HHS F31 HL154727NHLBI NIH HHS R01 HL127499NIGMS NIH HHS R01 GM131178
6 · The paper itself

Abstract

Diabetes is associated with increased risk of breast cancer and worse prognoses for cancer patients. Hyperglycemia can result in increased glycation, the process wherein crosslinkages are formed between sugars and extracellular matrix (ECM) proteins through the formation of advanced glycation endproducts (AGEs). Although accumulation of AGEs occurs naturally

Indexed as

HyperglycemiaNeoplasmsCell MovementCollagenGlucoseGlycation End Products, AdvancedHumansThiazolesalagebriumCollagenGlucoseGlycation End Products, AdvancedThiazoles

Identifiers

PMID36325938
PMCPMC10287025
OpenAlexW4308060033

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.